Terms: = Prostate cancer AND CTNNB1, P35222, 1499, ENSG00000168036, CTNNB AND Prognosis
9 results:
1. SCAND1 Reverses Epithelial-to-Mesenchymal Transition (EMT) and Suppresses prostate cancer Growth and Migration.
Eguchi T; Csizmadia E; Kawai H; Sheta M; Yoshida K; Prince TL; Wegiel B; Calderwood SK
Cells; 2022 Dec; 11(24):. PubMed ID: 36552758
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced prostate cancer: Differences in Genomic Landscape Based on Race.
Zimmerman R; Bilen MA; Heath EI; Nandagopal L; Swami U; Kessel A; Jaeger E; Wesolowski S; Hernanadez EJ; Chipman J; Mack A; Ravindranathan D; Maughan BL; Nussenzveig R; Yandell M; Kohli M; Lilly MB; Sartor AO; Agarwal N; Barata PC
Oncologist; 2022 Oct; 27(10):e815-e818. PubMed ID: 36036607
[TBL] [Abstract] [Full Text] [Related]
3. FLG Gene Mutation Up-regulates the Abnormal Tumor Immune Response and Promotes the Progression of prostate cancer.
Zhang P; An Z; Sun C; Xu Y; Zhang Z
Curr Pharm Biotechnol; 2022; 23(14):1658-1670. PubMed ID: 35422210
[TBL] [Abstract] [Full Text] [Related]
4. High expression of NPM1 via the Wnt/β-catenin signalling pathway might predict poor prognosis for patients with prostate adenocarcinoma.
Ruan Y; Xu H; Ji X
Clin Exp Pharmacol Physiol; 2022 Apr; 49(4):525-535. PubMed ID: 35108408
[TBL] [Abstract] [Full Text] [Related]
5. Tissue- and Blood-derived Genomic Biomarkers for Metastatic Hormone-sensitive prostate cancer: A Systematic Review.
Van der Eecken K; Vanwelkenhuyzen J; Deek MP; Tran PT; Warner E; Wyatt AW; Kwan EM; Verbeke S; Van Dorpe J; Fonteyne V; Lumen N; De Laere B; Ost P
Eur Urol Oncol; 2021 Dec; 4(6):914-923. PubMed ID: 34801437
[TBL] [Abstract] [Full Text] [Related]
6. Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant prostate cancer.
Isaacsson Velho P; Fu W; Wang H; Mirkheshti N; Qazi F; Lima FAS; Shaukat F; Carducci MA; Denmeade SR; Paller CJ; Markowski MC; Marshall CH; Eisenberger MA; Antonarakis ES
Eur Urol; 2020 Jan; 77(1):14-21. PubMed ID: 31176623
[TBL] [Abstract] [Full Text] [Related]
7. Identification of the Key MicroRNAs and the miRNA-mRNA Regulatory Pathways in prostate cancer by Bioinformatics Methods.
Li D; Hao X; Song Y
Biomed Res Int; 2018; 2018():6204128. PubMed ID: 30027097
[TBL] [Abstract] [Full Text] [Related]
8. Integrative Genomic Analysis of Coincident cancer Foci Implicates ctnnb1 and PTEN Alterations in Ductal prostate cancer.
Gillard M; Lack J; Pontier A; Gandla D; Hatcher D; Sowalsky AG; Rodriguez-Nieves J; Vander Griend D; Paner G; VanderWeele D
Eur Urol Focus; 2019 May; 5(3):433-442. PubMed ID: 29229583
[TBL] [Abstract] [Full Text] [Related]
9. Association analysis of Wnt pathway genes on prostate-specific antigen recurrence after radical prostatectomy.
Huang SP; Ting WC; Chen LM; Huang LC; Liu CC; Chen CW; Hsieh CJ; Yang WH; Chang TY; Lee HZ; Bao BY
Ann Surg Oncol; 2010 Jan; 17(1):312-22. PubMed ID: 19777185
[TBL] [Abstract] [Full Text] [Related]
